Stay updated on Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page was published. This likely reflects internal updates or corrections without changing the displayed study information.
    Difference
    0.0%
    Check dated 2026-08-30T05:56:31.000Z thumbnail image
  2. Check
    20 days ago
    No Change Detected
  3. Check
    27 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.5 label, replacing the previous v3.6.4 label; this reflects an update to the page's metadata rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-08-08T23:36:20.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.4, replacing the old v3.6.3, indicating a minor site update.
    Difference
    0.0%
    Check dated 2026-07-25T13:13:16.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    A new page revision tag, v3.6.3, has been added to the study page, replacing the previous v3.6.2 tag. This represents an update to the page's versioning, indicating a newer revision of the study record.
    Difference
    0.0%
    Check dated 2026-07-03T22:41:35.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces v3.6.0 on the page, indicating a backend software update; no visible content changes are implied by this revision tag.
    Difference
    0.0%
    Check dated 2026-06-26T20:51:49.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The SOPHIA study page now indicates that it is no longer recruiting participants. Enrollment is closed.
    Difference
    0.2%
    Check dated 2026-06-12T11:23:52.000Z thumbnail image

Stay in the know with updates to Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.